Nicaise Claude insider trades
Nicaise Claude has filed 17 Form 4s with the SEC that we hold, for Sarepta Therapeutics, Inc. (SRPT) (Director), Gain Therapeutics, Inc. (GANX) (Director), Filana Therapeutics, INC. (SAVA) (Director) and Chemomab Therapeutics Ltd. (CMMB) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $248.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,491 shares of Sarepta Therapeutics, Inc. worth $248.2K, dated 2025-03-12. The first filing on our record is dated 2022-03-08 and the latest 2026-07-17.
Sarepta Therapeutics, Inc. (SRPT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-12 | S, sale reported on Form 4 | 2,491 | $248.2K | 2025-03-13 |
Gain Therapeutics, Inc. (GANX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Filana Therapeutics, INC. (SAVA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Chemomab Therapeutics Ltd. (CMMB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1644162) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms